Amag Pharmaceuticals Inc., of Waltham, Mass., appointed Scott Myers president and CEO and to its board.
Nanomab Technology Ltd., of Shanghai, appointed Paul Edwards CEO and Robin Pakenham director of finance and operations. Company co-founder Hong Hoi Ting will serve as executive chair and chief scientific officer. Ian Miscampbell will join its board as a non-executive director.
Selecta Biosciences Inc., of Watertown, Mass., appointed Goran Ando to its board.